Impact Events

Brookfield India REIT Declares ₹473 Cr Distribution, ₹392.38 NAV
Brookfield India Real Estate Trust REIT announced its unaudited standalone and consolidated financial results for the quarter and half-year ended September 30, 2026. The Board of Directors approved a distribution of ₹4,730.32 million (₹5.70 per unit) for the quarter. This distribution includes interest payments, SPV debt and NCD repayment, dividend, and interest on fixed deposits and mutual fund gains. The Net Asset Value (NAV) as of September 30, 2026, was declared at ₹392.38 per unit. The record date for the distribution is November 05, 2026, with payment expected by November 13, 2026.

Avonmore Capital Q2 FY27 Revenue ₹44.36 Cr, Profit ₹10.84 Cr
Avonmore Capital & Management Services Ltd. reported unaudited consolidated financial results for the second quarter (2Q) of FY 2026-27. Total revenue stood at ₹44.36 crore, a significant increase from ₹37.04 crore in the same quarter last year, with profit rising to ₹10.84 crore from ₹5.99 crore. The company operates across Financial Services, Green Fuel Business, and Infrastructure Consulting. The Green Fuel Business, through its joint venture PGIPL, saw substantial growth with revenue at ₹202.24 crore and profit at ₹12.59 crore. Infrastructure Consulting also showed improvement, with revenue at ₹32.94 crore and profit at ₹2.90 crore. The Financial Services segment reported revenue of ₹9.93 crore and profit of ₹2.21 crore, impacted by market conditions. The company anticipates 20-25% growth in revenue and profitability for the current financial year.

BCL Industries consolidated PAT falls 7% YoY to ₹29.2 Cr as margins compress
BCL Industries' consolidated Q2 FY27 (quarter ended 30 September 2026) revenue came in at ₹695.28 Cr, down 3.4% YoY from ₹719.42 Cr but up 11.5% QoQ from ₹623.42 Cr. Consolidated PAT fell 7.4% YoY to ₹29.21 Cr (₹31.55 Cr a year ago) and dropped 17.8% QoQ from ₹35.52 Cr, with net margin compressing to about 4.2% from 5.66% in Q1 FY27 and roughly flat against 4.38% a year ago; PBT margin similarly slipped to 5.91% from 7.46% (QoQ) and 6.25% (YoY). A ₹1.99 Cr pre-tax gain on the sale of fixed assets at the Bathinda Oil & Vanaspati unit — tucked inside other income and explicitly flagged as incidental in the standalone notes — flatters the print; stripping it out, adjusted consolidated PAT growth is roughly -11.9% YoY versus the reported -7.4%, so the underlying decline is steeper than the headline. Standalone, the secondary basis, tells a sharper story: PAT fell 26.9% YoY and 31.7% QoQ to ₹15.47 Cr, a materially bigger drop than the consolidated number (>3% divergence) — the gap is driven by subsidiary Svaksha Distillery, whose segment contribution, though also down YoY, cushioned the group number, and whose minority stake showed zero non-controlling interest this quarter versus a positive NCI in both comparison quarters. The quarter's dominant operational story is the Ethanol Receiver Tank fire at the standalone 200 KLPD plant, disclosed as a Q1 FY27 event that knocked out production for over two months; the plant was reinstated on 28 August 2026, and a new 150 KLPD plant commissioned in July 2026 partly offset the lost volume, though management says not to the full targeted level — directly explaining why distillery topline and results trail what a clean quarter would show. An insurance claim for loss-of-profit is filed and under assessment, with settlement expected in Q3 FY27 and a positive P&L impact flagged by management. On guidance, the company gave no numeric revenue or PAT target for FY27 at the last concall, only a qualitative distillery EBITDA margin band of 10-12%; this filing discloses segment result (not segment EBITDA), so that band is not independently verifiable this quarter — it stays unresolved rather than met or missed. No analyst consensus or brokerage preview for this print turned up in search, consistent with thin sell-side coverage for a company this size, so vsStreet is unknown rather than assumed. No management press release or commentary beyond the bare board-outcome letter was available to reconcile against the numbers. Other corporate activity this quarter — the 25 September AGM, FY26 BRSR filing, trading-window closure ahead of results — was routine and doesn't move the P&L.

Mold-Tek Packaging Declares Unaudited Q2 FY27 Results
Mold-Tek Packaging Limited announced its un-audited financial results for the quarter and half-year ended September 30, 2026. The Board of Directors, in their meeting held on November 02, 2026, approved these results along with the Limited Review Report from the statutory auditors. The company reported increases in Net Profit, Sales, EBITDA, and Sales Volume for the second quarter compared to the previous year.

Mpl Plastics Ltd Approves Unaudited Financial Results for Q2 FY27
Mpl Plastics Ltd announced that its Board of Directors has approved the Unaudited Financial Results for the quarter and half-year ended September 30, 2026. The approval was granted during a Board meeting held on November 2, 2026, following a review by the Audit Committee. The meeting commenced at 1:30 p.m. and concluded at 2:00 p.m.

Epigral Q2 FY27 PAT Jumps 26% YoY to ₹64 Cr
Epigral Limited announced its un-audited financial results for the quarter ended September 30, 2026 (Q2 FY27). The company reported a 26% year-on-year growth in Profit After Tax (PAT), reaching ₹64 Crore, compared to ₹51 Crore in Q2 FY26. Quarterly revenue increased by 28% to ₹752 Crore from ₹589 Crore in the same period last fiscal. Sales volume grew by 6% despite challenging market conditions. The Derivatives & Specialty business contributed 57% of revenue. EBITDA stood at ₹136 Crore, with an EBITDA margin of 18% impacted by high raw material costs. For the first half of FY27 (H1FY27), revenue grew 21% to ₹1,461 Crore, EBITDA was ₹315 Crore, and PAT rose 25% to ₹164 Crore. The company is on schedule with its expansion plans for CPVC and ECH, expected to commission within a quarter.
Silverstorm Parks Board Meeting on Nov 7 to Approve Q2 FY27 Results
Silverstorm Parks And Resorts Ltd has announced that its Board of Directors will convene on November 7, 2026, to consider and approve the unaudited standalone and consolidated financial results for the quarter ended September 30, 2026. In line with SEBI regulations, the company has also informed about the closure of the trading window for its securities from October 1, 2026, to November 9, 2026, to prevent insider trading.

Eureka Forbes Q2 FY27 Revenue Up 15% YoY to ₹889.6 Cr
Eureka Forbes Limited reported strong financial results for the quarter and half-year ended September 30, 2026. For Q2 FY27, revenue from operations grew by 15.0% year-on-year (YoY) to ₹889.6 Cr, driven by high-teens growth in the product business, particularly in Water Purifiers and Emerging Categories. Adjusted EBITDA margins expanded by 43 basis points YoY to a lifetime high of 13.6%, with Adjusted EBITDA growing 18.8% YoY to ₹120.7 Cr. Profit After Tax (PAT) grew by 19.1% YoY to ₹73.3 Cr. For the six months ended September 30, 2026, revenue grew 15.1% YoY. The company highlighted broad-based growth across channels and categories, sustained momentum in emerging categories, and improved profitability despite inflationary pressures. The strong performance reinforces confidence in delivering a meaningful step-up in growth for FY27.

Epigral Ltd Declares Unaudited Financial Results for Q2 FY27
Epigral Limited announced its Unaudited Financial Results (Standalone & Consolidated) for the Second Quarter and Half Year ended September 30, 2026, following a Board Meeting held on November 2, 2026. The company also took on record the Limited Review Report issued by M/s. S R B C & CO LLP, Statutory Auditors. The meeting commenced at 12:00 Noon and concluded at 01:40 p.m. at the Registered Office in Ahmedabad.

Superhouse Ltd Board Meeting on Nov 14 to Approve Q2 Results
Superhouse Ltd has announced that its Board of Directors will convene on November 14, 2026, at 2:00 PM at its Head Office in Unnao. The primary agenda item for this meeting is the consideration and approval of the standalone and consolidated financial results for the quarter and half-year ended September 30, 2026. This meeting is being held in compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Mold-Tek Q2 FY27: standalone PAT +36% YoY to ₹21.1 Cr, EBITDA/kg beats guidance
Mold-Tek Packaging's standalone Q2 FY27 (quarter ended 30-Sep-2026) print: PAT ₹21.07 Cr, up 36.06% YoY from ₹15.48 Cr, on revenue of ₹274.23 Cr, up 30.73% YoY from ₹209.76 Cr — both running ahead of the 10.08% YoY volume growth, implying a richer product mix drove the gap. No analyst consensus preview for this specific quarter turned up in a search, so the print cannot be benchmarked against a street number; vsStreet is marked unknown rather than guessed. EBITDA rose 29.80% YoY to ₹51.27 Cr, with EBITDA/kg at ₹46.49 — up 30% YoY and above the ₹44-45/kg upgraded guidance management gave on the Q1 FY27 call, a beat on that specific metric. NPM expanded to 7.68% from 7.37% a year ago while OPM was roughly flat (18.70% vs 18.65%), but both eased versus Q1 FY27's 18.59% OPM/8.49% NPM — a sequential dip CMD J Lakshmana Rao frames as the normal Q2 seasonal low rather than deterioration, adding that raw-material cost increases were passed through under pre-agreed customer pricing to protect margins despite geopolitical-driven input volatility. Revenue is tracking toward the "₹1000+ Cr FY27" target flagged last quarter — H1 FY27 stands at ₹574.67 Cr, up 27.62% YoY — though Pharma Packaging's 26.30% YoY volume growth this quarter trails the 50% full-year pharma growth management guided for in July, even as it stays the fastest-growing segment (Food & FMCG incl. Q-Pack +23.70%, Paints +8.61%, Lubricants -12.32%). The Board completed its 1:1 bonus issue this quarter, allotting 3.32 Cr shares on 12-Oct-2026 against the 9-Oct-2026 record date — EPS is restated to ₹3.17 (basic, post-bonus) from ₹6.34 (pre-bonus) for the quarter; figures above use the pre-bonus EPS for comparability with prior periods. Separately, the company disclosed a ₹36.05 lakh tax demand notice on 1-Oct-2026, immaterial to the quarter's P&L. No exceptional items sat in either this quarter or the year-ago quarter, so the 36.06% PAT growth is a clean YoY comparison needing no adjustment. H2 FY27 catalysts flagged by management: commercial IODEX container production starting Q3 FY27, new packs for three more multinational customers from Q4 FY27, eye-dropper moulds ready by Q4 FY27 with production from Q1 FY28, and new dual-pack launches in Q4 — alongside new customer wins (Kannan Fiber, Mittal Polymers, Avakaaya Foods in food; Pharmaforce, Lifewise Pharmaceuticals in pharma) that should feed growth more into FY28 than the remainder of FY27.

Oswal Leasing Declares Un-audited Q2 FY27 Results
Oswal Leasing Ltd announced its un-audited financial results for the quarter and half-year ended September 30, 2026. The Board of Directors approved these results along with the Statement of Assets and Liabilities, Cash Flow Statement, and the Limited Review Report from statutory auditors M/s K R Aggarwal & Associates. The extract of the financial results will be published in newspapers as per listing regulations. The board meeting commenced at 11:00 AM and concluded at 01:30 PM.

Switching Technologies Gunther Board Meeting on Nov 13, 2026
Switching Technologies Gunther Ltd has announced that its Board of Directors will convene on November 13, 2026, to consider and approve the unaudited standalone and consolidated financial results for the quarter and half-year ended September 30, 2026. The meeting will be held via video conferencing. Concurrently, the company has closed its trading window for designated persons from November 13, 2026, in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015, until the financial results are declared.

Epigral Ltd Declares Un-Audited Q2 FY27 Results
Epigral Limited announced the outcome of its Board Meeting held on November 2, 2026. The Board approved and took on record the Un-Audited Financial Results (Standalone & Consolidated) for the Second Quarter and Half Year ended September 30, 2026. The Limited Review Report from statutory auditors M/s. S R B C & CO LLP was also noted. The meeting took place at the company's registered office in Ahmedabad.

Eureka Forbes Board Approves Q2 FY27 Results & Director Re-appointment
Eureka Forbes Limited's Board of Directors met on November 02, 2026, to approve the unaudited standalone and consolidated financial results for the Quarter and Half Year ended September 30, 2026, along with the Limited Review Report. The board also approved the re-appointment of Mr. Homi Katgara as Non-Executive, Independent Director for a second term of five years, commencing January 31, 2027, subject to shareholder approval. The meeting commenced at 12:27 PM IST and concluded at 01:20 PM IST. The results and re-appointment details are available on the company's website.













